Wiviott, S., Raz, I., Bonaca, M., Mosenzon, O., Kato, E., Cahn, A., Silverman, M., Zelniker, T., Kuder, J., Murphy, S., Bhatt, D., Leiter, L., McGuire, D., Wilding, J., Ruff, C., Gause-Nilsson, I., Fredriksson, M., Johansson, P., Langkilde, A., Sabatine, M.,
DECLARE-TIMI 58 Investigators:
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
N. Engl. J. Med. 380 (4), 347-357, 2019.